8/19/15 12:11 | 8/18/15 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | P,COO | S.d | -661 | 73.49 | 33 | -9 | -8 | 101 | D | 54 | 27 | 15 | 9 | 16 | 6 | 11 | 9 | -2 | -9 | -1 | -9 | -21 | -6 |
6/19/15 13:04 | 6/18/15 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | P,COO | S.d | -806 | 70.03 | 29 | -12 | -10 | 101 | D | 45 | 28 | 31 | 0 | 8 | 5 | 5 | 4 | 1 | -6 | -5 | 5 | -7 | -18 |
3/20/15 11:07 | 3/19/15 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | P,COO | S.d | -889 | 68.99 | 27 | -13 | -11 | 101 | D | 82 | 23 | 13 | 31 | 11 | 8 | 6 | 3 | 0 | -3 | 0 | 0 | 5 | -13 |
12/5/14 13:27 | 12/3/14 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | P,COO | S.d | -1,495 | 58.99 | 29 | -25 | -20 | 101 | D | 84 | 51 | 9 | 2 | -7 | 4 | 2 | 2 | -3 | -6 | -3 | 13 | 13 | 14 |
12/2/14 10:59 | 11/28/14 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | P,COO | S.d | -28 | 58.99 | 33 | 0 | 0 | 101 | D | 77 | 40 | 11 | 1 | -5 | 6 | 2 | 1 | 2 | -2 | -4 | 12 | 15 | 19 |
8/14/14 15:47 | 8/13/14 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | P,COO | S.d | -944 | 56.33 | 25 | -17 | -14 | 105 | D | 110 | 10 | 12 | 23 | 6 | 5 | 5 | 1 | 2 | 2 | 8 | -3 | 11 | 19 |
2/19/14 12:38 | 2/18/14 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | P,COO | S.d | -588 | 52.49 | 32 | -11 | -10 | 105 | D | 108 | 54 | 10 | 19 | 16 | 8 | 6 | 3 | -1 | 2 | 9 | -8 | 11 | 22 |
2/14/14 13:24 | 2/12/14 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | P,COO | S.d | -616 | 50.49 | 32 | -12 | -10 | 105 | D | 115 | 52 | 7 | 19 | 15 | 8 | 6 | 4 | -1 | 2 | 8 | -11 | 11 | 21 |
2/5/14 08:05 | 2/3/14 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | P,COO | S | -659 | 48.70 | 32 | -14 | -11 | 105 | D | 100 | 44 | -4 | 8 | 12 | 4 | 1 | -1 | 2 | 2 | 13 | -9 | 11 | 24 |
1/14/14 12:07 | 1/13/14 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | P,COO | S.d | -340 | 48.90 | 25 | -7 | -6 | 119 | D | 117 | 43 | -6 | -8 | 14 | 7 | 4 | 1 | 0 | -2 | 8 | 5 | 15 | 33 |
1/10/14 15:01 | 1/9/14 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | P,COO | S.d | -321 | 46.49 | 25 | -7 | -5 | 119 | D | 120 | 43 | -6 | -6 | 13 | 12 | 2 | 3 | 1 | -1 | 7 | 8 | 16 | 27 |
1/9/14 11:57 | 1/8/14 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | P,COO | S.d | -22 | 46.49 | 26 | 0 | 0 | 119 | D | 119 | 40 | -5 | -8 | 12 | 12 | 3 | 2 | 0 | 0 | 8 | 12 | 17 | 28 |
6/4/13 14:35 | 6/3/13 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | P,COO | S | -676 | 45.06 | 24 | -15 | -11 | 117 | D | 83 | 75 | 41 | 31 | 15 | 2 | 1 | 1 | -2 | 3 | 3 | 1 | -11 | 13 |
5/14/13 10:43 | 5/13/13 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | P,COO | S.d | -1,305 | 45.19 | 23 | -29 | -18 | 132 | D | 84 | 79 | 51 | 32 | 11 | 10 | 3 | 1 | 3 | 3 | 3 | 13 | -4 | 4 |
3/5/13 12:26 | 3/1/13 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | P,COO | S.d | -409 | 34.99 | 14 | -12 | -8 | 142 | D | 50 | 44 | 27 | 8 | 6 | 3 | 5 | 2 | 3 | 5 | 12 | 31 | 32 | 57 |
11/30/12 13:29 | 11/28/12 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | P,COO | S.d | -374 | 32.01 | 17 | -12 | -8 | 142 | D | 78 | 67 | 24 | 18 | 5 | 10 | 2 | 3 | -1 | -2 | -9 | 8 | 41 | 26 |
11/7/12 11:06 | 11/6/12 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | P,COO | S.d | -155 | 31.00 | 11 | -5 | -3 | 142 | D | 45 | 56 | 24 | 12 | 2 | 1 | 6 | 3 | -3 | -3 | 2 | 8 | 42 | 41 |
10/5/12 16:41 | 10/4/12 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | P,COO | S.d | -160 | 32.00 | 13 | -5 | -3 | 142 | D | 50 | 62 | 23 | 14 | 20 | 6 | 7 | 4 | 0 | -3 | -1 | 4 | 25 | 57 |
9/7/12 10:58 | 9/6/12 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | P,COO | S.d | -300 | 30.00 | 12 | -10 | -7 | 136 | D | 46 | 46 | 21 | 12 | 9 | 9 | 9 | 4 | 0 | 1 | 6 | 6 | 25 | 62 |
2/3/12 10:26 | 2/1/12 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | COO | S | -150 | 25.00 | 14 | -6 | -4 | 136 | D | 28 | 20 | 32 | 22 | 22 | 20 | 18 | 21 | 0 | -2 | -1 | 2 | 10 | 37 |
4/27/11 15:00 | 4/26/11 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | COO | S | -258 | 27.00 | 10 | -10 | -7 | 125 | D | 235 | 13 | 28 | 23 | 11 | 6 | 6 | 4 | 1 | -15 | -13 | -20 | -21 | 0 |
1/27/10 15:13 | 1/26/10 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | COO | S.d | -202 | 20.25 | 14 | -10 | -8 | 117 | D | -31 | 164 | 36 | 37 | 54 | 31 | 7 | 14 | -1 | 0 | 6 | 23 | 17 | 13 |
1/19/10 11:24 | 1/14/10 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | COO | S | -23 | 18.00 | 9 | -1 | -1 | 117 | D | -33 | 113 | 29 | 28 | 42 | 25 | 20 | 6 | 0 | -2 | 14 | 35 | 31 | 13 |
1/12/10 16:26 | 1/11/10 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | COO | S.d | -124 | 16.84 | 7 | -7 | -6 | 118 | D | -36 | 90 | 32 | 24 | 37 | 25 | 19 | 14 | 5 | 6 | 15 | 38 | 39 | 23 |
1/6/10 14:01 | 1/5/10 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | COO | S.d | -99 | 15.00 | 4 | -7 | -5 | 120 | D | -38 | 53 | 18 | 15 | 18 | 14 | 5 | 4 | 0 | 13 | 28 | 59 | 43 | 42 |
9/11/09 17:10 | 9/11/09 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | COO | S.d | -19 | 14.00 | 7 | -1 | -1 | 122 | D | -34 | -55 | 60 | 4 | -12 | 7 | 6 | 7 | 1 | 1 | -3 | -10 | 64 | 51 |
8/10/07 14:28 | 8/9/07 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | P,CRS,Pe | S.d | -212 | 42.40 | 31 | -5 | -9 | 53 | D | 116 | 43 | 27 | 10 | 2 | 4 | 7 | 4 | -2 | 1 | -6 | 2 | 28 | 65 |
11/9/06 16:44 | 11/8/06 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | P,CRS,Pe | S.d | -79 | 32.19 | 22 | -2 | -5 | 48 | D | 65 | 52 | 11 | 8 | -3 | -7 | 9 | 6 | 1 | -1 | -8 | 8 | 28 | 42 |
5/10/06 13:17 | 5/8/06 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | P,CRS,Pe | S.d | -92 | 30.63 | 14 | -3 | -6 | 48 | | | | | | | | | | -3 | -5 | -9 | 1 | 5 | 32 |
11/9/04 09:40 | 11/4/04 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | P,Percep | S.ad | -184 | 18.84 | 5 | -10 | -82 | 2 | D | 54 | 15 | 2 | 3 | -1 | 1 | 2 | 2 | 0 | 2 | 3 | 27 | -6 | 10 |
11/8/04 14:25 | 11/4/04 | PRXL | Parexel International Corp | MA | Health | Biolab | Commercial Physical & Biologi | Goldberg Mark A | MA | O | P,Percep | S.ed | -98 | 9.98 | 5 | -10 | -82 | 2 | D | 55 | 16 | 0 | 5 | 1 | -3 | 2 | 3 | 0 | 0 | 3 | 27 | -5 | 10 |